Tag: RootsAnalysis
The opportunity for AR / VR based digital marketing service providers in healthcare
Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Servicev Providers Market, 2020-2030” report to its list of offerings.
Over 230 cobots, having variable payload capacities and degrees of freedom, have already been deployed, or are being actively adopted across various industries, including the life sciences and pharmaceutical industry, claims
Collaborative robotsor cobots allow companies to automate their processes, are easy to program anddeploy, can increase productivity manifolds
The global collaborative robots (cobots) market is projected to be worth USD 18 billion
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.
The medical device CRO market is estimated to be worth USD 15.7 billion in 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CRO Market (2nd Edition), 2020-2030”.
Endocannabinoid System Targeted Therapeutics Market, 2020-2030
Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings
More than 65 industry players across the world are presently engaged in evaluating the clinical applications of over 180 cannabinoid-derivatives that target the human endocannabinoid signalling system
Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically
The endocannabinoid system targeted therapeutics market - Roots Analysis post
Roots Analysis is pleased to announce the publication of its recent study, titled, “Endocannabinoid System Targeted Therapeutics Market, 2020-2030
The endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030, growing at an annualized rate of 30%, claims Roots Analysis
Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings.
The “Antibody Contract Manufacturing Market, 2020-2030” report - Roots Analysis'
Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody...
companies required expertise and infrastructure to offer contract manufacturing services for a variety of antibody-based products - Roots Analysis'
Roots Analysis has done a detailed study on Antibody Contract Manufacturing Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
The antibody contract manufacturing market is estimated to be worth USD 17 billion - Roots Analysis'
The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well
The antibody contract manufacturing market is projected to reach USD 17 billion by 2030 - Roots Analysis'
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone
The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report - Roots Analysis'
The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.
The bispecific antibody therapeutics pipeline has evolved significantly over the past few years - Roots Analysis'
With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications.
The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16% - Roots Analysis'
Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
